CETUXIMAB for Rectal cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 542 adverse event reports in the FDA FAERS database where CETUXIMAB was used for Rectal cancer.
Most Reported Side Effects for CETUXIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 1,549 | 10.6% | 234 | 514 |
| Rash | 883 | 6.1% | 61 | 145 |
| Diarrhoea | 874 | 6.0% | 123 | 434 |
| Neutropenia | 744 | 5.1% | 88 | 137 |
| Nausea | 663 | 4.6% | 50 | 284 |
| Malignant neoplasm progression | 662 | 4.6% | 225 | 172 |
| Dyspnoea | 542 | 3.7% | 55 | 225 |
| Decreased appetite | 541 | 3.7% | 75 | 255 |
| Vomiting | 533 | 3.7% | 63 | 293 |
| Death | 518 | 3.6% | 518 | 69 |
| Anaemia | 508 | 3.5% | 69 | 177 |
| Myelosuppression | 493 | 3.4% | 4 | 317 |
| Pyrexia | 477 | 3.3% | 62 | 298 |
| Fatigue | 463 | 3.2% | 65 | 158 |
| White blood cell count decreased | 463 | 3.2% | 22 | 182 |
Other Indications for CETUXIMAB
Colorectal cancer metastatic (1,960)
Colon cancer (1,522)
Product used for unknown indication (1,369)
Squamous cell carcinoma of head and neck (1,130)
Colorectal cancer (909)
Head and neck cancer (885)
Colon cancer metastatic (553)
Adenocarcinoma of colon (469)
Squamous cell carcinoma (283)
Oropharyngeal cancer (227)
Other Drugs Used for Rectal cancer
CAPECITABINE (2,976)
OXALIPLATIN (2,402)
FLUOROURACIL (1,610)
BEVACIZUMAB (1,546)
TIPIRACIL\TRIFLURIDINE (1,297)
IRINOTECAN (985)
LEUCOVORIN (660)
REGORAFENIB (505)
PANITUMUMAB (374)
FRUQUINTINIB (367)